Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

Executive shakeup with Guilder out at Taiwan's TWi

Taiwan's TWi Pharmaceutical said CEO and president Tina Guilder has resigned, making it less than a year since she joined from Teva Pharmaceuticals after the company broke with the Israeli firm on U.S. marketing plans in March.

J&J brings 500 jobs to Florida with new shared services HQ

New Jersey-based pharma giant Johnson & Johnson already has a presence in Florida, but it's about to get bigger--by 500 jobs.

Venter's HLI nabs Millennium Health COO to oversee global expansion

J. Craig Venter's Human Longevity Inc. (HLI) has appointed a chief operating officer to manage its burgeoning genome sequencing operation. Mark Windham has taken up the position, jumping ship from drug-testing lab Millennium Health, where he also served as COO.

Kelly Martin takes over at Malin in post-acquisition phase reshuffle

Former Elan CEO Kelly Martin is back at the helm of a business. The controversial dealmaker has taken over as CEO of Malin, the life science investment fund he helped to set up and guide to a €330 million ($380 million) IPO earlier this year.

AstraZeneca lures Sean Bohen from Genentech to fill top R&D post

AstraZeneca has filled the vacancy at the head of its R&D organization. Sean Bohen is set to take up the post next month after being persuaded to swap a position at the heart of early-stage R&D at Genentech for a chance to guide AstraZeneca's late-phase hopefuls toward approval.

Troubled Lundbeck targets 1,000 layoffs in HQ, commercial revamp

Lundbeck is going on a cost-cutting binge. Amid falling sales--and a few months after a new CEO took the helm--the Danish drugmaker says it will cut loose 1,000 employees as part of a plan to save 3 billion kronor, or about $445 million, by 2017.

Art Krieg leads Checkmate as it comes out of stealth mode with $20M

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Merck tallies 36,000 job cuts in 5 years of restructuring

The good news for Merck & Co.'s far-flung workforce: The job cuts hanging over your heads for the past five years are almost finished. The not-so-good news: Several thousand payroll reductions are yet to come.

At Epizyme, CEO Gould steps aside and Bazemore takes the reins

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

GSK rehires former China government affairs director Shi

Reuters reported that GlaxoSmithKline has rehired former China government affairs director Vivian Shi, who was at one point investigated internally by the company as a possible source of leaks into a bribery probe.